Global Research Hotspots and Publications of Ganoderma lucidum (Lingzhi): A Bibliometric Analysis from 1994 to 2024
DOI:
https://doi.org/10.62767/jecacm601.5814Keywords:
Ganoderma lucidum, network data analysis, antioxidantAbstract
Background: Traditional Chinese medicine holds a unique and invaluable position internationally. Ganoderma lucidum, a traditional Chinese herbal medicine, is anti-oxidative, anti-aging, anti-tumor, anti-inflammatory, and effective in the treatment of diabetes. However, there is still a lack of systematic bibliometric analysis with regard to Ganoderma lucidum. Objective: This study uses bibliometric analysis methods to assess the published literature on Ganoderma lucidum, determine the current state of Ganoderma research, visualize development trends and research hotspots, and provide references for research on the topic. Methods: This study searched the Web of Science Core Collection database for literature published between 1994 and 2024, and used WPS Excel, VOSviewer, and CiteSpace to analyze and apply information on authors, institutions, journals, regions, keywords, etc., included in the collection, and construct visual literature collaboration networks. Results: A total of 3320 publications were ultimately analyzed. The three most prolific authors in the past 30 years are Ang Ren, Liang Shi and Mingwen Zhao. The Chinese Academy of Sciences is the most outstanding institution in the field of Ganoderma lucidum research. And the journal INTERNATIONAL JOURNAL OF MEDICAL MUSHROOMS has made outstanding contributions in the field. China has published the most publications in this field, followed by the United States. In recent years, the pharmacological effects of Ganoderma lucidum on regulating the gut microbiota have attracted a lot of attention. Conclusion: From 1994 to 2024, research attention to Ganoderma lucidum has continued to increase, as such it may be a potential research hotspot in the field of traditional medicine. This study examined the development trends and research hotspots of relevant scholars.
References
Seweryn E, Ziała A, Gamian A. Health-promoting of polysaccharides extracted from Ganoderma lucidum. Nutrients 2021; 13(8): 2725.
Liu H, Cheng J, Wang X, et al. Structure Identification of Ganoderma lucidum Spore Polysaccharides and Their Antitumor Activity In Vivo. Molecules 2024; 29(10): 2348.
Ji C, Yang Y, Fu Y, et al. Improvement of Ganoderma lucidum water extract on the learning and memory impairment and its mechanism in d-galactose-induced aging mice. Journal of Functional Foods 2022; 99: 105322.
Cheng PG, Teoh TC, Rizman-Idid M. Chemical compounds and computational prediction of their inhibitory effects on the HIV-1 gp120 receptor by lingzhi or reishi medicinal mushroom, Ganoderma lucidum (agaricomycetes), with antler-like morphology of fruiting bodies. International Journal of Medicinal Mushrooms 2021; 23(7): 63-77.
Ahmad MF, Ahmad FA, Hasan N, et al. Ganoderma lucidum: Multifaceted mechanisms to combat diabetes through polysaccharides and triterpenoids: A comprehensive review. International Journal of Biological Macromolecules 2024; 268(Pt 1): 131644.
Tajik A, Samadlouie HR, Salek Farrokhi A, et al. Optimization of chemical conditions for metabolites production by Ganoderma lucidum using response surface methodology and investigation of antimicrobial as well as anticancer activities. Frontiers in Microbiology 2024; 14: 1280405.
Kolniak-Ostek J, Oszmianski J, Szyjka A, et al. Anticancer and antioxidant activities in Ganoderma lucidum wild mushrooms in Poland, as well as their phenolic and triterpenoid compounds. International Journal of Molecular Sciences 2022; 23(16): 9359.
Sanodiya BS, Thakur GS, Baghel RK, et al. Ganoderma lucidum: a potent pharmacological macrofungus. Current Pharmaceutical Biotechnology 2009; 10(8): 717-742.
Lie Y. Liezi - Tang Wen; Huayashi Bookstore: Beijing, China, 2002.
Luan Y, Hou W. Shennong's Herbal; People's Military Medical Publishing House: Beijing, China, 2010.
Lin Z. Study on the integration of traditional Chinese and western medicine to interpret the discussion on Ganoderma lucidum in Shennong's Herbal Classic. Chinese Journal of Pharmacology and Toxicology 2019; 33(09): 645-646.
Lin Z. From prehistory to modern times: A brief history of the development of Ganoderma lucidum medicine in China. Mycological Research 2024; 22(01): 1-8.
Li S. Compendium of Materia Medica New: Upper and Lower Volumes; Huaxia Publishing House: Beijing, China, 2004.
Chairul SM, Hayashi Y. Lanostanoid triterpenes from Ganoderma applanatum. Phytochemistry 1994; 35(5): 1305-1308.
Paterson RRM. Ganoderma—A therapeutic fungal biofactory. Phytochemistry 2006; 67(18): 1985-2001.
Cör D, Knez Ž, Knez Hrnčič M. Antitumour, antimicrobial, antioxidant and antiacetylcholinesterase effect of Ganoderma lucidum terpenoids and polysaccharides: A review. Molecules 2018; 23(3): 649.
Baby S, Johnson AJ, Govindan B. Secondary metabolites from Ganoderma. Phytochemistry 2015; 114: 66-101.
Ahmad MF. Ganoderma lucidum: Persuasive biologically active constituents and their health endorsement. Biomedicine & Pharmacotherapy 2018; 107: 507-519.
Wang L, Li J, Zhang J, et al. Traditional uses, chemical components and pharmacological activities of the genus Ganoderma P. Karst.: a review. RSC Advances 2020; 10(69): 42084-42097.
Galappaththi MCA, Patabendige NM, Premarathne BM, et al. A review of Ganoderma triterpenoids and their bioactivities. Biomolecules 2022; 13(1): 24.
Liu Y, Wen H, Xu R, et al. Semisynthesis and antitumor activity of endertiin B and related triterpenoids from Ganoderma lucidum. Organic & Biomolecular Chemistry 2024; 22(24): 4978-4986.
Wu GS, Guo JJ, Bao JL, et al. Anti-cancer properties of triterpenoids isolated from Ganoderma lucidum—a review. Expert Opinion on Investigational Drugs 2013; 22(8): 981-992.
Ahmad MF, Ahmad FA, Khan MI, et al. Ganoderma lucidum: A potential source to surmount viral infections through β-glucans immunomodulatory and triterpenoids antiviral properties. International Journal of Biological Macromolecules 2021; 187: 769-779.
Zhao C, Fan J, Liu Y, et al. Hepatoprotective activity of Ganoderma lucidum triterpenoids in alcohol-induced liver injury in mice, an iTRAQ-based proteomic analysis. Food Chemistry 2019; 271: 148-156.
Wang C, Liu X, Lian C, et al. Triterpenes and aromatic meroterpenoids with antioxidant activity and neuroprotective effects from Ganoderma lucidum. Molecules 2019; 24(23): 4353.
Dudhgaonkar S, Thyagarajan A, Sliva D. Suppression of the inflammatory response by triterpenes isolated from the mushroom Ganoderma lucidum. International Immunopharmacology 2009; 9(11): 1272-1280.
Li P, Liu L, Huang S, et al. Anti-cancer effects of a neutral triterpene fraction from Ganoderma lucidum and its active constituents on SW620 human colorectal cancer cells. Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Anti-Cancer Agents) 2020; 20(2): 237-244.
Ren L, Zhang J, Zhang T. Immunomodulatory activities of polysaccharides from Ganoderma on immune effector cells. Food Chemistry 2021; 340: 127933.
Guo C, Guo D, Fang L, et al. Ganoderma lucidum polysaccharide modulates gut microbiota and immune cell function to inhibit inflammation and tumorigenesis in colon. Carbohydrate Polymers 2021; 267: 118231.
Zhang X, Wang J, Zhang T, et al. Updated Progress on Polysaccharides with Anti-Diabetic Effects through the Regulation of Gut Microbiota: Sources, Mechanisms, and Structure—Activity Relationships. Pharmaceuticals 2024; 17(4): 456.
Ma HT, Hsieh JF, Chen ST. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry 2015; 114: 109-113.
Han XQ, Yue GL, Yue RQ, et al. Structure elucidation and immunomodulatory activity of a beta glucan from the fruiting bodies of Ganoderma sinense. PLoS One 2014; 9(7): e100380.
Liu KS, Zhang C, Dong HL, et al. GSP-2, a polysaccharide extracted from Ganoderma sinense, is a novel toll-like receptor 4 agonist. PLoS One 2019; 14(8): e0221636.
Chen Z, Qin W, Lin H, et al. Inhibitory effect of polysaccharides extracted from Changbai Mountain Ganoderma lucidum on periodontal inflammation. Heliyon 2023; 9(2): e13205.
Kao PF, Wang SH, Hung WT, et al. Structural Characterization and Antioxidative Activity of Low‐Molecular‐Weights Beta‐1, 3‐Glucan from the Residue of Extracted Ganoderma lucidum Fruiting Bodies. BioMed Research International 2012; 2012(1): 673764.
Wu Q, Xie Y, Deng Z, et al. Ergosterol peroxide isolated from Ganoderma lucidum abolishes microRNA miR-378-mediated tumor cells on chemoresistance. PLoS One 2012; 7(8): e44579.
Jiao C, Chen W, Tan X, et al. Ganoderma lucidum spore oil induces apoptosis of breast cancer cells in vitro and in vivo by activating caspase-3 and caspase-9. Journal of Ethnopharmacology 2020; 247: 112256.
Wu X, Cao J, Li M, et al. An integrated microbiome and metabolomic analysis identifies immunoenhancing features of Ganoderma lucidum spores oil in mice. Pharmacological Research 2020; 158: 104937.
Liu Y, Lai G, Guo Y, et al. Protective effect of Ganoderma lucidum spore extract in trimethylamine‐N‐oxide‐induced cardiac dysfunction in rats. Journal of Food Science 2021; 86(2): 546-562.
Jiao C, Xie Y, Yun H, et al. The effect of Ganoderma lucidum spore oil in early skin wound healing: interactions of skin microbiota and inflammation. Aging (Albany NY) 2020; 12(14): 14125.
Jiao C, Yun H, Liang H, et al. An active ingredient isolated from Ganoderma lucidum promotes burn wound healing via TRPV1/SMAD signaling. Aging (Albany NY) 2022; 14(13): 5376.
Additional Files
Published
Data Availability Statement
The data presented in this study are available on request from the corresponding author.
Issue
Section
License
Copyright (c) 2025 The Author(s)
This work is licensed under a Creative Commons Attribution 4.0 International License.
